FTSE MIB
33.977,83 +231,17 (+0,69%) Dow Jones
37.903,29 +87,37 (+0,23%) Nasdaq
15.605,48 -52,34 (-0,33%) Nikkei 225
38.236,07 -37,98 (-0,10%) Petrolio
79,73 +0,73 (+0,92%) Bitcoin EUR
54.065,82 +888,07 (+1,67%)
Atrion Corporation (ATRI)
Dopo ore:
- GlobeNewswire
Atrion Corporation Announces Election of New Director
ALLEN, Texas, Sept. 20, 2023 (GLOBE NEWSWIRE) -- Atrion Corporation (NASDAQ: ATRI) announced the election today of Jeannette Bankes as a director, effective immediately. Ms. Bankes brings to our Board over 32 years of experience at major medical device and pharmaceutical companies. Since March 2019, Ms. Bankes has served as the President and General Manager of the Global Surgical Franchise at Alcon Inc. From August 2004 to March 2019, Ms. Bankes served in leadership positions across multiple div
- GlobeNewswire
Atrion Reports Second Quarter 2023 Results
ALLEN, Texas, Aug. 08, 2023 (GLOBE NEWSWIRE) -- Atrion Corporation (NASDAQ: ATRI) today announced its results for the second quarter ended June 30, 2023. Revenues for the second quarter of 2023 totaled $43.8 million compared to $48.9 million for the same period in 2022. For the quarter ended June 30, 2023, operating income was $7.4 million, down $3.7 million from the comparable 2022 period, and net income was $6.6 million, down $2.8 million from the same period in 2022. Second quarter 2023 dilut
- GlobeNewswire
Atrion Reports First Quarter 2023 Results
ALLEN, Texas, May 08, 2023 (GLOBE NEWSWIRE) -- Atrion Corporation (NASDAQ: ATRI) today announced its results for the first quarter ended March 31, 2023. Revenues for the first quarter of 2023 totaled $40.0 million compared to $47.1 million for the same period in 2022. For the quarter ended March 31, 2023, operating income was $4.5 million, down $5.8 million from the comparable 2022 period, and net income was $3.5 million, down $5.0 million from the same period in 2022. First quarter 2023 diluted
